GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (OTCPK:INRLF) » Definitions » Pretax Margin %

Valneva SE (Valneva SE) Pretax Margin % : 179.89% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Valneva SE Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Valneva SE's Pre-Tax Income for the three months ended in Mar. 2024 was $64.0 Mil. Valneva SE's Revenue for the three months ended in Mar. 2024 was $35.6 Mil. Therefore, Valneva SE's pretax margin for the quarter that ended in Mar. 2024 was 179.89%.

The historical rank and industry rank for Valneva SE's Pretax Margin % or its related term are showing as below:

INRLF' s Pretax Margin % Range Over the Past 10 Years
Min: -70.25   Med: -33.06   Max: 2.96
Current: -14.03


INRLF's Pretax Margin % is ranked better than
70.14% of 1028 companies
in the Biotechnology industry
Industry Median: -155.98 vs INRLF: -14.03

Valneva SE Pretax Margin % Historical Data

The historical data trend for Valneva SE's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Pretax Margin % Chart

Valneva SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.69 -59.19 -20.10 -40.08 -64.16

Valneva SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.45 -51.14 -82.87 -67.44 179.89

Competitive Comparison of Valneva SE's Pretax Margin %

For the Biotechnology subindustry, Valneva SE's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Valneva SE's Pretax Margin % falls into.



Valneva SE Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Valneva SE's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-107.556/167.625
=-64.16 %

Valneva SE's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=64.041/35.601
=179.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valneva SE  (OTCPK:INRLF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Valneva SE Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Valneva SE's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE (Valneva SE) Business Description

Traded in Other Exchanges
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, & third-party products; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The majority is from the Commercialized vaccines segment & geographically from the United States.